Healthcare -
Biotechnology - NASDAQ - US
$ 9.94
7.81 %
$ 220 M
Market Cap
-4.56
P/E
INMB - ACCOUNTS PAYABLE
Accounts Payable INMB - INmune Bio, Inc.
7.9 M
LAST VALUE
44.14%
2 YEAR CAGR
70.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR